Lazard Welcomes Will Thompson as Managing Director, Healthcare Services
Lazard (NYSE: LAZ) has announced that Will Thompson will join the firm as Managing Director, Healthcare on November 4, 2024. Based in London, Thompson will be part of Lazard's financial advisory practice for Europe and its global healthcare group. This appointment marks Thompson's return to Lazard, where he previously worked from 1998 to 2004.
Thompson joins from Barclays, where he was Managing Director and Head of European Healthcare for nearly a decade. His appointment, along with Michele Colocci's recent hiring as Vice Chairman, Investment Banking and Managing Director, Healthcare, underscores Lazard's commitment to strengthening its product and sector teams.
Lazard's global healthcare business has experienced significant growth, advising on transactions worth over $245 billion since 2020. The firm's healthcare team operates across 22 countries, reinforcing its position as a leading global franchise in the sector.
Lazard (NYSE: LAZ) ha annunciato che Will ThompsonDirettore Generale, Settore Sanitario il 4 novembre 2024. Con sede a Londra, Thompson sarà parte della pratica di consulenza finanziaria di Lazard per l'Europa e del suo gruppo globale dedicato alla sanità. Questa nomina segna il ritorno di Thompson in Lazard, dove ha lavorato precedentemente dal 1998 al 2004.
Thompson proviene da Barclays, dove ha ricoperto il ruolo di Direttore Generale e Capo del Settore Sanitario Europeo per quasi un decennio. La sua nomina, insieme all'assunzione recente di Michele Colocci come Vice Presidente, Investment Banking e Direttore Generale, Settore Sanitario, sottolinea l'impegno di Lazard nel rafforzare i suoi team di prodotto e settoriali.
Il business globale di Lazard nel settore sanitario ha registrato una crescita significativa, fornendo consulenze su transazioni per un valore superiore a $245 miliardi dal 2020. Il team sanitario dell'azienda opera in 22 paesi, rafforzando la sua posizione come franchising globale di riferimento nel settore.
Lazard (NYSE: LAZ) ha anunciado que Will Thompson se unirá a la firma como Director General, Salud el 4 de noviembre de 2024. Con sede en Londres, Thompson formará parte de la práctica de asesoría financiera de Lazard para Europa y de su grupo global de salud. Este nombramiento marca el regreso de Thompson a Lazard, donde trabajó anteriormente de 1998 a 2004.
Thompson proviene de Barclays, donde fue Director General y Jefe de Salud Europea durante casi una década. Su nombramiento, junto con la reciente contratación de Michele Colocci como Vicepresidente, Banca de Inversión y Director General, Salud, subraya el compromiso de Lazard de fortalecer sus equipos de producto y sectoriales.
El negocio global de salud de Lazard ha experimentado un crecimiento significativo, asesorando en transacciones por más de $245 mil millones desde 2020. El equipo de salud de la firma opera en 22 países, reforzando su posición como una franquicia global líder en el sector.
라자르(Lazard, NYSE: LAZ)는 윌 톰프슨(Will Thompson)이 2024년 11월 4일부터 관리 이사, 헬스케어로 합류한다고 발표했습니다. 런던에 본사를 둔 톰프슨은 유럽의 라자르 금융 자문 실무와 글로벌 헬스케어 그룹의 일원이 될 것입니다. 이번 임명은 톰프슨이 1998년부터 2004년까지 라자르에서 근무했던 경험을 반영하는 것입니다.
톰프슨은 바클레이(Barclays)에서 유럽 헬스케어 담당 관리 이사로 거의 10년간 재직했습니다. 그의 임명과 함께 투자은행 부문 부회장 및 관리 이사로 최근 채용된 미켈레 콜로치(Michele Colocci)의 채용은 라자르가 제품 및 섹터 팀을 강화하려는 의지를 보여줍니다.
라자르의 글로벌 헬스케어 사업은 2020년 이후로 $2450억 이상의 거래에 대한 자문을 제공하며, 상당한 성장을 경험했습니다. 이 회사의 헬스케어 팀은 22개국에서 운영되며, 이 분야에서 글로벌 선도 프랜차이즈로서의 입지를 강화하고 있습니다.
Lazard (NYSE: LAZ) a annoncé que Will Thompson rejoindra l'entreprise en tant que Directeur Général, Santé le 4 novembre 2024. Basé à Londres, Thompson fera partie de la pratique de conseil financier de Lazard pour l'Europe et de son groupe mondial de santé. Cette nomination marque le retour de Thompson chez Lazard, où il a travaillé précédemment de 1998 à 2004.
Thompson vient de Barclays, où il était Directeur Général et Responsable de la Santé Européenne pendant près d'une décennie. Sa nomination, ainsi que celle de Michele Colocci récemment engagée en tant que Vice-Président, Banque d'Investissement et Directeur Général, Santé, souligne l'engagement de Lazard à renforcer ses équipes de produits et de secteurs.
Le secteur mondial de la santé de Lazard a connu une croissance significative, conseillant sur des transactions d'une valeur de plus de 245 milliards de dollars depuis 2020. L'équipe santé de l'entreprise opère dans 22 pays, renforçant ainsi sa position en tant que franchise mondiale de premier plan dans le secteur.
Lazard (NYSE: LAZ) hat bekannt gegeben, dass Will Thompson am 4. November 2024 als Geschäftsführer, Gesundheitswesen zu der Firma stoßen wird. Mit Sitz in London wird Thompson Teil der europäischen Finanzberatungsabteilung von Lazard und der globalen Gesundheitsgruppe sein. Diese Ernennung markiert Thompsons Rückkehr zu Lazard, wo er zuvor von 1998 bis 2004 gearbeitet hat.
Thompson kommt von Barclays, wo er fast ein Jahrzehnt als Geschäftsführer und Leiter des europäischen Gesundheitswesens tätig war. Seine Ernennung, zusammen mit der kürzlichen Einstellung von Michele Colocci als stellvertretender Vorsitzender, Investment Banking und Geschäftsführer, Gesundheitswesen, unterstreicht Lazards Engagement, seine Produkt- und Sektor-Teams zu stärken.
Das globale Gesundheitsgeschäft von Lazard hat ein erhebliches Wachstum erfahren und berät seit 2020 bei Transaktionen im Wert von über 245 Milliarden US-Dollar. Das Gesundheitsteam des Unternehmens ist in 22 Ländern tätig, was die Position als führendes globales Franchise in diesem Sektor stärkt.
- Appointment of Will Thompson as Managing Director, Healthcare, strengthening Lazard's healthcare team
- Recent hiring of Michele Colocci as Vice Chairman, Investment Banking and Managing Director, Healthcare
- Lazard's healthcare business has advised on transactions worth over $245 billion since 2020
- Global healthcare team operates across 22 countries
- None.
Mr. Thompson’s appointment marks a return to Lazard; he was at the firm earlier in his career from 1998 to 2004. He joins Lazard from Barclays, where he spent close to ten years as Managing Director and Head of European Healthcare. Previously, he was Managing Director in the healthcare practices of UBS, Close Brothers and Morgan Stanley.
Mr. Thompson’s appointment follows that of Michele Colocci, who joined Lazard as Vice Chairman, Investment Banking and Managing Director, Healthcare in June. These two senior hires reflect Lazard’s wider commitment to investing in its best-in-class product and sector teams. Lazard’s preeminent healthcare business is supported by a global network of sector-focused bankers operating at scale across 22 countries. The franchise has undergone a period of significant growth in recent years, with the team advising on transactions representing over
ABOUT LAZARD
Founded in 1848, Lazard is one of the world's preeminent financial advisory and asset management firms, with operations in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241014379259/en/
MEDIA
Poppy Trowbridge
+ 44 020 7187 2065
Poppy.Trowbridge@lazard.com
Source: Lazard, Inc.
FAQ
When will Will Thompson join Lazard as Managing Director, Healthcare?
What is Will Thompson's previous experience before joining Lazard (LAZ)?
How much has Lazard's healthcare business grown in recent years?
Who else has recently joined Lazard's healthcare team?
